Disulfiram: Dopamine β-Hydroxylase Inhibitor and Proteasomal Activity Modulator

Executive Summary: Disulfiram (CAS No. 97-77-8) is an anti-alcoholism drug and copper-binding agent that acts as a dopamine β-hydroxylase inhibitor and potent proteasomal chymotrypsin-like activity inhibitor (APExBIO). In vitro, Disulfiram—especially in complex with copper—induces apoptotic cell death in breast cancer MDA-MB-231 cells by inhibiting proteasome activity (Jiang et al., 2024). In vivo, oral Disulfiram at 50 mg/kg/day for 29 days inhibits tumor growth by 74% in MDA-MB-231 xenograft mice (BCA-Protein.com). Disulfiram also covalently inhibits gasdermin D, blocking pyroptotic cell death mechanisms. This dossier provides atomic, verifiable claims, application constraints, and workflow guidance for scientific research use only.

Biological Rationale

Disulfiram is widely recognized for its clinical use in alcohol aversion therapy, functioning as an acetaldehyde dehydrogenase inhibitor. Its copper-binding property extends its utility into oncology and cell signaling research. Disulfiram targets dopamine β-hydroxylase, impacting catecholamine biosynthesis in both neurobiological and cancer contexts. Recent evidence highlights Disulfiram’s role as a covalent modulator of gasdermin D (GSDMD), an effector in pyroptotic cell death, further broadening its research relevance (Jiang et al., 2024). Its dual action on the proteasome and pyroptosis pathways positions Disulfiram as a tool for dissecting proteostasis and inflammatory signaling in cancer and immunology studies.

Mechanism of Action of Disulfiram

• Acetaldehyde Dehydrogenase Inhibition: Disulfiram blocks acetaldehyde dehydrogenase, causing acetaldehyde accumulation after ethanol intake, resulting in aversive symptoms (APExBIO).
• Dopamine β-Hydroxylase Inhibition: Disulfiram inhibits dopamine β-hydroxylase, reducing norepinephrine synthesis from dopamine, with downstream effects on neurotransmitter balance (Tofacitinib.biz).
• Proteasomal Chymotrypsin-Like Activity Inhibition: Disulfiram, especially as a copper complex, inhibits the proteasome's chymotrypsin-like activity, causing proteotoxic stress and apoptosis in cancer cells (Jiang et al., 2024).
• Gasdermin D (GSDMD) Cysteine Modification: Disulfiram covalently modifies cysteine-191/192 on GSDMD, blocking pore formation and downstream pyroptosis (Jiang et al., 2024).
• Copper-Dependent Mechanisms: The Disulfiram-copper complex is essential for optimal proteasome inhibition and apoptosis induction in breast cancer MDA-MB-231 cells (BCA-Protein.com).

Evidence & Benchmarks

• Disulfiram (50 mg/kg/day, oral, 29 days) inhibits tumor growth by 74% in MDA-MB-231 xenograft mice (BCA-Protein.com, source).
• Disulfiram-copper complex induces apoptosis in MDA-MB-231 breast cancer cells via proteasome inhibition (Tofacitinib.biz, source).
• Disulfiram covalently modifies GSDMD at C191/192, blocking pyroptosis in inflammasome signaling (Jiang et al., 2024, DOI).
• Disulfiram is insoluble in water but dissolves in DMSO (≥12 mg/mL) and ethanol (≥24.2 mg/mL with ultrasonic assistance); warming to 37°C and sonication optimizes solubility (APExBIO, product page).
• Stock solutions should be stored at -20°C and are not recommended for long-term storage post-preparation (APExBIO, product page).
• Shipping requires blue ice for small-molecule stability (APExBIO, product page).

This article extends prior resources such as Disulfiram (SKU A4015): Data-Driven Solutions for Cancer Research by detailing GSDMD targeting and pyroptosis modulation, and updates Disulfiram as a Dual-Mode Proteasome and Pyroptosis Pathway Inhibitor with new evidence from Jiang et al. (2024).

Applications, Limits & Misconceptions

Disulfiram’s validated applications include:

• Inhibition of proteasomal chymotrypsin-like activity in cancer research.
• Apoptotic cancer cell death induction in breast cancer MDA-MB-231 lines.
• Modulation of inflammasome signaling via GSDMD inhibition.
• Alcohol aversion therapy (clinical, not for research use).

Common Pitfalls or Misconceptions

• Disulfiram is not recommended for diagnostic or therapeutic use outside controlled research (APExBIO).
• Long-term storage of working solutions leads to compound degradation; always prepare fresh aliquots.
• Water solubility is negligible; use DMSO or ethanol with ultrasonic assistance for dissolution.
• Copper is required for maximal proteasome inhibition; Disulfiram alone is less effective in some models.
• Disulfiram does not inhibit ASC oligomerization or caspase-1 processing in AIM2/NLRC4 inflammasome pathways (Jiang et al., 2024).

For further mechanistic detail, see Disulfiram at the Crossroads of Cancer and Inflammasome Research, which this article clarifies with updated mechanistic boundaries and solubility data.

Workflow Integration & Parameters

• Dissolve Disulfiram in DMSO (≥12 mg/mL) or ethanol (≥24.2 mg/mL, ultrasonic assistance) for stock solutions.
• Warming to 37°C and brief sonication improves dissolution rates.
• Store stock solutions at -20°C; avoid repeated freeze-thaw cycles.
• For in vivo studies, oral gavage at 50 mg/kg/day in mice is validated for breast cancer xenograft inhibition.
• Shipping is performed on blue ice to ensure compound stability.

For experimental troubleshooting and integration into cell viability assays, see this workflow-focused article, which this piece extends by providing precise solubility and storage best practices.

Conclusion & Outlook

Disulfiram, as supplied by APExBIO, is a proven research tool for inhibiting dopamine β-hydroxylase, modulating proteasomal signaling, and blocking GSDMD-dependent pyroptosis. Its efficacy in breast cancer models and its dual action in proteostasis and inflammasome pathways make it valuable for translational and mechanistic research. Researchers must observe solubility, storage, and workflow parameters to ensure reproducibility. Future research may further elucidate Disulfiram’s role in combinatorial cancer and inflammatory disease models, especially as new molecular targets such as GSDMD are validated (Jiang et al., 2024).